WO2007020432A2 - High strength devices and composites - Google Patents
High strength devices and composites Download PDFInfo
- Publication number
- WO2007020432A2 WO2007020432A2 PCT/GB2006/003049 GB2006003049W WO2007020432A2 WO 2007020432 A2 WO2007020432 A2 WO 2007020432A2 GB 2006003049 W GB2006003049 W GB 2006003049W WO 2007020432 A2 WO2007020432 A2 WO 2007020432A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- polymer
- oriented device
- anhydride
- oriented
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/502—Plasticizers
Definitions
- This invention relates to biodegradable polymeric devices and composites, particularly to bioresorbable devices and composites and to artifacts made therefrom and their uses.
- High strength trauma fixation devices plates, screws, pins etc
- metal typically titanium and stainless steel
- metal devices have several well known disadvantages.
- amorphous or semi-crystalline bioresorbable polymers such as poly (glycolic acid) (PGA) and poly (lactic acid) (PLA) are typically used to produce low load bearing devices- such as suture anchors, screws or tacs.
- PGA poly (glycolic acid)
- PLA poly (lactic acid)
- One of the main criteria for using resorbable materials is that they carry out a mechanical function, degrade within a reasonable timeframe (for example, less than 3 yrs), and are ideally replaced by bone when used in bone sites.
- these materials are not used in high load bearing applications because they are not strong or stiff enough to resist deformation under high load.
- Drawn P(L)LA fibres and monoliths are also known.
- drawn materials such as fibres and rods in which the polymer is oriented in the direction of drawing
- the directional strength is dramatically increased.
- Products from these combined approaches include fibre reinforced composites, using drawn fibre and a polymer matrix, and self-reinforced materials, using extruded billets which are die drawn into self reinforced rods.
- WO 01/46501 discloses preparing a melt blend of polyester and multicarboxyiic acid having improved processability in an extruder and also having improved crystallization and absorption properties, envisaged for use in manufacturing nappies.
- high strength fibres can be produced by incorporating plasticisers in the polymer blend, such as lauric acid, a fatty acid known from WO 03/004071 , to plasticise and accelerate the degradation of P(L)LA, and drawing the fibres to orient the polymer.
- plasticisers such as lauric acid, a fatty acid known from WO 03/004071
- the mechanical properties of drawn fibre were not compromised by the incorporation of plasticiser.
- incorporating these plasticisers increased the degree of draw of the fibres during conventional hot drawing but decreased the drawing temperature.
- an oriented implantable, biodegradable device formed from a homogeneous polymer blend comprising a poly lactic acid (PLA) in admixture, in an amount of not more than 10% by weight of the polymer blend, with an additive which plasticises polymer draw and which is a degradation accelerant wherein polymer comprised within the polymer blend is in uniaxial, biaxial or triaxial orientation.
- PVA poly lactic acid
- the additive is biocompatible.
- the additive may be suitable for any application and is advantageously suitable for use in medical applications.
- the additive is a carboxylic acid or precursor thereof.
- an acid precursor is a carboxyl containing compound and is selected from an acid anhydride, ester or other acid precursor.
- the acid may be a mono or poly saturated or unsaturated acid, more particularly a mono or diacid.
- the acid is a monoacid or precursor thereof.
- the acid is suitably a C 4- 24 carboxylic acid or precursor.
- suitable additives include the group consisting of hexanoic acid, octanoic acid, decanoic acid, lauric acid, myristic acid, crotonic acid, 4-pentenoic acid, 2-hexenoic acid, undecylenic acid, petroselenic acid, oleic acid, erucic acid, 2,4-hexadienoic acid, linoleic acid, linolenic acid, benzoic acid, hydrocinnamic acid, 4-isopropylbenzoic acid, ibuprofen, ricinoleic acid, adipic acid, suberic acid, phthalic acid, 2-bromolauric acid, 2,4- hydroxydodecanoic acid, monobutyrin, 2-hexyldecanoic acid, 2- butyloctanoic acid, 2-ethylhexanoic acid, 2-methylvaleric acid, 3- methylvaleric acid, 4-methylvaleric acid, 2-e
- the oriented PLA polymer of the invention is characterised by improved degradation properties, equivalent mechanical properties and enhanced draw with respect to the original drawn PLA polymer.
- Reference herein to an oriented device is to a device comprised of oriented polymer as known in the art, also known as aligned polymer, wherein the polymer is in uniaxial, biaxial or triaxial alignment.
- polymers comprise discrete polymer chains which may be aligned or oriented to render the polymer in uniaxial, biaxial or triaxial alignment. Alignment or orientation is suitably conferred by further processing in suitable manner and as hereinafter defined.
- the oriented device of the invention is therefore distinct from polymer which has not been further processed to confer orientation, and in which polymer chains are typically in random alignment. Orientation may be determined by techniques as known in the art for example scanning electron microscopy (SEM), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), X-ray, optical microscopy and the like.
- a advantageous additive for use in the invention is lauric acid or benzoic acid. This may be employed as the acid per se or, if desired, as a precursor, for example as the anhydride.
- the additive will not only control the rate of degradation but will delay the onset of the degradation process relative to the acid. This delay may be achieved, aptly by the use of precursors which are convertible to the acidic form of the additive. Suitable precursors are acid anhydrides which will, in an in vivo environment, hydrolyse to the corresponding acid.
- Example anhydrides include lauric anhydride and benzoic anhydride.
- the polymer blend will contain not more than 5%, and more aptly not more than 2%, by weight of the additive and typically the blend will contain not more than 1% by weight of the additive.
- Example blends will contain not more than 2%, ideally not more than 1 %, by weight of the blend of lauric acid or a precursor thereof.
- the amount of the additive chosen will also depend upon the nature of the additive and the rate of degradation desired.
- the polymeric component of the polymer blends useful for the invention essentially comprise a biodegradable PLA, including homopolymers, (block) copolymers, blends, individual or mixed isomers and the like, which may be bioresorbable, bioerodible or display any other form of degradation, for example instability to water, heat or acid, polymer.
- the PLA may be suitable for any application and is advantageously suitable for medical applications, for example is suitable for implantation into the human or animal body.
- An oriented device of the invention may be single phase (amorphous) or biphasic (semi crystalline and amorphous).
- Suitably blends are of miscible polymers.
- Suitable biodegradable PLA's are selected from poly(lactic acid), isomers thereof including P(L)LA, P(D)LA, P(D 1 L)LA, blends and copolymers thereof.
- a co-polymer for use in the blend of the invention may comprise more than one PLA as hereinbefore defined or may comprise other known biodegradable polymeric components copolymerised therewith, such as polyesters, including poly(lactic acid), poly(glycolic acid), copolymers of lactic and glycolic acids, copolymers of lactic and glycolic acid with poly(ethylene glycol), poly(e-caprolactone), poly(3-hydroxybutyrate), poly(p-dioxanone), poly(propylene fumarate), poly(trimethylene carbonate) and the like.
- polyesters including poly(lactic acid), poly(glycolic acid), copolymers of lactic and glycolic acids, copolymers of lactic and glycolic acid with poly(ethylene glycol), poly(e-caprolactone), poly(3-hydroxybutyrate), poly(p-dioxanone), poly(propylene fumarate), poly(trimethylene carbonate) and the like.
- the copolymer is a copolymer with another poly(lactic acid) or with poly glycolic acid, for example a copolymer of poly(lactic acids) such as P(L)LA/P(D)LA copolymer, or a copolymer of poly(lactic acid) and glycolic acid (known as PLA/PGA co-polymer).
- the blend may, in addition to the additive, consist of a blend of PLAs or copolymers as hereinbefore defined with other biodegradable polymeric components, for example, polyesters, for .
- a blend of polylactic acid or PLA/PGA co-polymer either alone or in admixture with each other.
- Molecular weight of the polymeric component may be selected according to the particular polymer to be used and the intended use of the device of the invention, and therefore the required strength and modulus.
- the polymeric component has number average molecular weight (Mn) in oriented form in the range in excess of 30,000 daltons or alternatively in the range 50,000 to 500,000 daltons.
- Mn number average molecular weight
- Molecular weight of the oriented device for higher strength applications, for example oriented fibres may be in the range 100,000 to 400,000 daltons.
- Molecular weight may be determined in known manner, for example by gel permeation chromatography (GPC), viscometry or the like.
- polymeric component is selected with an intrinsic viscosity (IV), in the range 1 to 10, and more particularly 2 to 5.
- IV intrinsic viscosity
- the oriented device may also contain fillers such as osteoconductive materials and the like and/or biological actives such as hydroxyapatite.
- the oriented device of the invention may be provided in the form of fibres, drawn monoliths such as rods and the like, spun or moulded devices or may be used to produce high strength composites reinforced by component fibres, drawn monoliths, spun or moulded polymer and the like.
- Fibres may be continuous or chopped.
- Reference herein to fibres includes fibres, yarns, strands, whiskers, filaments, ribbons, tapes and the like.
- Drawn devices may be singly or multiply drawn.
- the oriented device of the invention is characterised by properties of high strength.
- the device has a tensile strength in excess of about 150 MPa up to about 2000 MPa depending on the polymer components and the form thereof.
- Tensile strength may be in the range from about 800 to about 2000 MPa, for example about 800 to about 1000 or about 1000 to about 2000 MPa, for fibre form devices, or in the range about 150 to about 800 MPa for drawn monoliths, spun or moulded polymer. This compares with a tensile strength of undrawn PLA fibres of the order of 70 MPa.
- the polymer matrix is a bioresorbable polymer, and may be selected from any bioresorbable polymer, for example a polyester, such as PLA or the like and its isomers and copolymers and blends thereof as hereinbefore defined.
- the polymer matrix is selected from PLA, P(L)LA, P(D)LA, P(D 1 L)LA, PGA, polycaprolactone (PCL) and the like and (block) copolymers and blends thereof.
- a matrix polymer may be formed from a homogeneous polymer blend comprising the polymer(s) in admixture, in an amount of not more than 10% by weight of the polymer blend, with an additive which plasticises polymer and which is a degradation accelerant as hereinbefore defined.
- a composite of the invention may also contain fillers such as osteoconductive materials and/or biological actives such as hydroxyapatite in the matrix and/or the oriented device.
- the composite comprises oriented device present in a known manner, for example provided as random or aligned fibres, a fabric in woven or unwoven or braided form or as a scrim, mesh, preform or prepreg.
- Fabrics may be mats, felts, veils, braided, knitted, punched, non-crimp, polar-, spiral- or uni-weaves, tailored fibre placement fabrics and the like.
- Composite may comprise continuous or chopped oriented fibres of the invention.
- the oriented device may be present in any desired amount, for example in an amount of from about 1 wt% to about 70wt% of the composite.
- a composite of the invention is biodegradable and may comprise any implantable device where temporary residence only is required.
- implantable devices include suture anchors, soft tissue anchors, interference screws, tissue engineering scaffolds, maxillo-facial plates, fracture fixation plates and rods and the like.
- the composite of the invention is characterised by properties of high strength.
- the composite of the invention has tensile strength in excess of 150 MPa up to 800 MPa depending on the constituent polymer components and matrix polymer and the composite form.
- Tensile strength is, for example, in the range about
- a process for the preparation of an oriented device as hereinbefore defined comprising preparing a polymer blend comprising a polylactic acid in admixture, in an amount of not more than 10% by weight of the polymer blend, with an additive which plasticises polymer draw and which is a degradation accelerant as hereinbefore defined, and processing to orient polymer whereby polymer is in uniaxial, biaxial or triaxial orientation.
- Polymer component is commercially available or may be prepared by processes as known in the art.
- the polymer blends used for the present invention may be produced by known processes such as solution blending wherein the additive is blended directly into a solution of a polymeric component comprising for example, PLA in chloroform, by melt blending in melt phase, or by dry blending the solid polymer and additive materials and then solution blending the solid mixture with solvent such as chloroform. The solution blend is then dried to form a solid blend or is cast onto a surface and dried.
- the polymer blend is cast, compression moulded or extruded into a form suitable for shaping and orienting, for example moulding or extruding as monolith such as billets or rods, or fibre or film, and oriented by any known process that induces orientation into a polymer, selected from uniaxial, biaxial or triaxial orientation as hereinbefore defined.
- Casting or compression-moulding may be conducted by rendering the solid blend in melt phase for shaping into a desired form for orienting.
- Extrusion may be of powder or pellets as a dry blend from a hopper with extrusion via a suitable die to the desired shape.
- orienting is by aligning melt phase polymer blend and cooling, more particularly by drawing, spinning or moulding melt phase polymer blend to orient polymer chains in the direction of draw or spin, or axis or direction of moulding, and cooling, such as drawing, for example fibre drawing produces increased strength and modulus fibre, or (hydrostatic) die drawing produces an increased strength or modulus rod or the like, spinning for example gel spinning or solution spinning produces increased strength or modulus fibre, moulding for example Shear Controlled Orientation in Injection Moulding (SCORIM) produces increased strength or modulus fibre, rod or shaped polymer, and the like.
- high strength oriented device may be produced by processing to orient the polymer using any of the following processes: -
- polyester fibre e.g. P(L)LA fibre
- hydrostatic die drawing or die drawing to produce a high strength-high modulus fast degrading polyester rod (e.g. P(L)LA rod);
- solution processing such as gel spinning or solution spinning (to produce fibre at ambient temperature from solution, with subsequent solvent removal;
- Drawing, spinning and moulding processes are known in the art. Drawing is undertaken, for example, by feeding the moulded film or extrudate at elevated temperature through a die and drawing the polymer, whereby the polymer chains orient in the direction of drawing, and cooling. Drawing may be conducted in two stages or passes.
- an oriented device of the invention may be used to prepare a polymer composite as hereinbefore defined.
- Composites according to the invention may be prepared by providing the oriented device in desired form and combining with matrix polymer as hereinbefore defined.
- Matrix polymer is suitably combined in solid, solution or melt form with the oriented device in accordance with the invention and hardened for example by moulding, compression moulding or drying.
- Matrix may be combined by blending, impregnation, infusion, injection or the like as known in the art.
- an additive- containing blend as hereinbefore defined may be utilized to prepare both oriented device and matrix component of a composite material which is then fabricated into a high strength biodegradable composite device as hereinbefore or hereinbelow defined.
- an oriented device or a composite thereof as hereinbefore defined as an implantable biodegradable device such as a high strength trauma fixation device suitable for implantation into the human or animal body, for example plates, screws, pins, rods, anchors or scaffolds, in particular suture anchors, soft tissue anchors, interference screws, tissue engineering scaffolds, maxillo-facial plates, fracture fixation plates and rods and the like.
- Figure 1 illustrates the degradation profile of drawn P(L)LA and drawn P(L)LA/nica acid (LA) fibres with time.
- Figure 2 illustrates the molecular weight (Mn) change of drawn P(L)LA and drawn P(L)LA/LA fibres with time.
- the viscous solutions were cast by poured them out into release paper trays, in order to produce thick sheets of polymer suitable for subsequent granulation.
- the sheets were left to dry for 2 days in the fume cupboard before undergoing the subsequent drying procedure:
- the sheets were then granulated with the Cumberland mechanical grinder (fitted with 3mm sieve), after having been dipped into liquid nitrogen to render them more brittle. All the granules were further dried under vacuum at 100 0 C for 4 hours, and left under vacuum at room temperature for 3 days.
- the extruder was fitted with a general-purpose 12mm screw with a 25:1 L/D ratio.
- the extruder was fitted with a 2mm (diameter) die (coated) with a L/D ratio of 6:1.
- the fibre was produced using a flat temperature profile of 240° C for all zones.
- a nominal 0.5mm diameter fibre was produced (using maximum screw speed of 50rpm) and hauled off at a rate of 16 meters per minute.
- the diameter of the fibre was monitored during the run using a Mitutoyo laser micrometer.
- the extruded fibre was sealed in a foil pouch containing a desiccant sachet and then stored in a freezer at - 20° C prior to further processing.
- Fibre drawing was carried out using a customised drawing rig.
- the rig consists of two sets of godets and heated plate (hot shoe).
- the godets were preset to rotate at different speeds.
- the fibre was feed from a spindle, through the 1 st set of godets, drawn over the hot shoe and around the 2 nd set of godets.
- the drawn fibre was finally collected on a Leesona fibre winder.
- the fibres were drawn under various temperatures and speeds to produced fibres with different properties as shown in Table 1.
- Fibre was drawn using a batch zone drawing process.
- a cylindrical brass zone (outer diameter 25mm, inner diameter 5mm, 63mm length) was attached to a moving plate.
- the temperature was controlled using a temperature probe connected to the zone and temperature controls.
- a clamp was fixed at a given height above the zone, 1 metre length of fibre was clamped at 1 end, threaded through the zone (using a brass rod), and the load was attached to the free end of the fibre. Fibre was then drawn under various speed, load and zone temperatures.
- Carrier gas Helium
- Table 3 shows the amount of lauric acid contained in each P(L)UVLA fibre.
- the fibres were subjected to in vitro degradation by immersion in standard phosphate buffer solution (PBS), maintained at 37 0 C.
- PBS phosphate buffer solution
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008526546A JP2009504929A (en) | 2005-08-18 | 2006-08-16 | High-strength devices and composite materials |
CA002619571A CA2619571A1 (en) | 2005-08-18 | 2006-08-16 | High strength devices and composites |
EP06765297A EP1922091A2 (en) | 2005-08-18 | 2006-08-16 | High strength devices and composites |
AU2006281248A AU2006281248A1 (en) | 2005-08-18 | 2006-08-16 | High strength devices and composites |
US12/064,156 US20080305144A1 (en) | 2005-08-18 | 2006-08-16 | High Strength Devices and Composites |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0516943.8 | 2005-08-18 | ||
GB0516943A GB0516943D0 (en) | 2005-08-18 | 2005-08-18 | High strength fibres and composites |
GB0523318A GB0523318D0 (en) | 2005-11-16 | 2005-11-16 | High strength fibres and composites |
GB0523318.4 | 2005-11-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007020432A2 true WO2007020432A2 (en) | 2007-02-22 |
WO2007020432A3 WO2007020432A3 (en) | 2007-12-21 |
Family
ID=37671232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2006/003049 WO2007020432A2 (en) | 2005-08-18 | 2006-08-16 | High strength devices and composites |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080305144A1 (en) |
EP (1) | EP1922091A2 (en) |
JP (1) | JP2009504929A (en) |
AU (1) | AU2006281248A1 (en) |
CA (1) | CA2619571A1 (en) |
WO (1) | WO2007020432A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007313009A (en) * | 2006-05-25 | 2007-12-06 | Terumo Corp | Stent |
WO2009019477A2 (en) * | 2007-08-07 | 2009-02-12 | Smith & Nephew Plc | Coating |
WO2010017153A3 (en) * | 2008-08-06 | 2011-03-31 | Medtronic, Inc. | Medical devices and methods including blends of biodegradable polymers |
US9770534B2 (en) | 2007-04-19 | 2017-09-26 | Smith & Nephew, Inc. | Graft fixation |
US9815240B2 (en) | 2007-04-18 | 2017-11-14 | Smith & Nephew, Inc. | Expansion moulding of shape memory polymers |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0329654D0 (en) | 2003-12-23 | 2004-01-28 | Smith & Nephew | Tunable segmented polyacetal |
CN101594831B (en) | 2006-11-30 | 2011-09-14 | 史密夫和内修有限公司 | Fiber reinforced composite material |
JP5520814B2 (en) | 2007-04-19 | 2014-06-11 | スミス アンド ネフュー インコーポレーテッド | Multimodal shape memory polymer |
JP5286505B2 (en) * | 2011-01-19 | 2013-09-11 | 東洋製罐株式会社 | Biodegradable resin composition |
WO2013038399A1 (en) * | 2011-09-18 | 2013-03-21 | Bio Plasmar Ltd | Bio-degradable compositions and use thereof |
US8834915B2 (en) | 2012-03-30 | 2014-09-16 | Manli International Ltd. | Drug-containing bioabsorbable fibers and implants |
US11325281B2 (en) * | 2018-07-23 | 2022-05-10 | Ut-Battelle, Llc | Rapid manufacturing of tailored preforms |
US11612754B2 (en) * | 2018-12-21 | 2023-03-28 | Tepha, Inc. | Resorbable nonwoven pouches for medical device implants |
CN111671981A (en) * | 2020-06-24 | 2020-09-18 | 杭州锐健马斯汀医疗器材有限公司 | Absorbable composite material for interface screw sheath and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0635274A2 (en) * | 1993-07-21 | 1995-01-25 | United States Surgical Corporation | Plasticizers for fibers used to form surgical devices |
WO2000001426A1 (en) * | 1998-07-07 | 2000-01-13 | Smith & Nephew Plc | Blend of bioresorbable polymers |
WO2001046501A2 (en) * | 1999-12-22 | 2001-06-28 | Kimberly-Clark Worldwide, Inc. | Synthetic fiber |
WO2003004071A1 (en) * | 2001-07-04 | 2003-01-16 | Smith & Nephew Plc | Biodegradable polymer systems |
WO2003064531A1 (en) * | 2002-01-31 | 2003-08-07 | Smith & Nephew Plc | High strength bioresorbables containing poly-glycolic acid |
WO2005014718A1 (en) * | 2003-07-19 | 2005-02-17 | Smith & Nephew Plc | High strength bioreabsorbable co-polymers |
Family Cites Families (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE758156R (en) * | 1970-05-13 | 1971-04-28 | Ethicon Inc | ABSORBABLE SUTURE ELEMENT AND ITS |
US3797499A (en) * | 1970-05-13 | 1974-03-19 | Ethicon Inc | Polylactide fabric graphs for surgical implantation |
US3736646A (en) * | 1971-10-18 | 1973-06-05 | American Cyanamid Co | Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures |
US4137921A (en) * | 1977-06-24 | 1979-02-06 | Ethicon, Inc. | Addition copolymers of lactide and glycolide and method of preparation |
US4181983A (en) * | 1977-08-29 | 1980-01-08 | Kulkarni R K | Assimilable hydrophilic prosthesis |
US5110852A (en) * | 1982-07-16 | 1992-05-05 | Rijksuniversiteit Te Groningen | Filament material polylactide mixtures |
US4627952A (en) * | 1982-09-03 | 1986-12-09 | Celanese Corporation | Injection molding process |
US4523591A (en) * | 1982-10-22 | 1985-06-18 | Kaplan Donald S | Polymers for injection molding of absorbable surgical devices |
US4438253A (en) * | 1982-11-12 | 1984-03-20 | American Cyanamid Company | Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same |
US4636215A (en) * | 1984-01-11 | 1987-01-13 | Rei, Inc. | Combination tray and condylar prosthesis for mandibular reconstruction and the like |
US4990161A (en) * | 1984-03-16 | 1991-02-05 | Kampner Stanley L | Implant with resorbable stem |
US5527337A (en) * | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
JP2561853B2 (en) * | 1988-01-28 | 1996-12-11 | 株式会社ジェイ・エム・エス | Shaped memory molded article and method of using the same |
US5444113A (en) * | 1988-08-08 | 1995-08-22 | Ecopol, Llc | End use applications of biodegradable polymers |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5633002A (en) * | 1988-10-04 | 1997-05-27 | Boehringer Ingelheim Gmbh | Implantable, biodegradable system for releasing active substance |
FR2641692A1 (en) * | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
US5294395A (en) * | 1989-09-01 | 1994-03-15 | Ethicon, Inc. | Thermal treatment of theraplastic filaments for the preparation of surgical sutures |
DE58908155D1 (en) * | 1989-09-15 | 1994-09-08 | N Proizv Ob Edinenie Kompleksn | ENDOPROTHESIS OF THE HIP JOINT. |
US7208013B1 (en) * | 1990-06-28 | 2007-04-24 | Bonutti Ip, Llc | Composite surgical devices |
ATE131373T1 (en) * | 1991-05-24 | 1995-12-15 | Synthes Ag | ABSORBABLE TENDON AND BONE REINFORCEMENT DEVICE |
US5275601A (en) * | 1991-09-03 | 1994-01-04 | Synthes (U.S.A) | Self-locking resorbable screws and plates for internal fixation of bone fractures and tendon-to-bone attachment |
US5383931A (en) * | 1992-01-03 | 1995-01-24 | Synthes (U.S.A.) | Resorbable implantable device for the reconstruction of the orbit of the human skull |
US5333624A (en) * | 1992-02-24 | 1994-08-02 | United States Surgical Corporation | Surgical attaching apparatus |
US5407445A (en) * | 1992-05-20 | 1995-04-18 | Cytrx Corporation | Gel composition for implant prosthesis and method of use |
CA2124842C (en) * | 1992-10-02 | 2003-07-15 | Patrick R. Gruber | A melt-stable lactide polymer fabric and process for manufacture thereof |
US5437918A (en) * | 1992-11-11 | 1995-08-01 | Mitsui Toatsu Chemicals, Inc. | Degradable non-woven fabric and preparation process thereof |
US5716410A (en) * | 1993-04-30 | 1998-02-10 | Scimed Life Systems, Inc. | Temporary stent and method of use |
US5417712A (en) * | 1994-02-17 | 1995-05-23 | Mitek Surgical Products, Inc. | Bone anchor |
US5626861A (en) * | 1994-04-01 | 1997-05-06 | Massachusetts Institute Of Technology | Polymeric-hydroxyapatite bone composite |
US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5702656A (en) * | 1995-06-07 | 1997-12-30 | United States Surgical Corporation | Process for making polymeric articles |
FI98136C (en) * | 1995-09-27 | 1997-04-25 | Biocon Oy | A tissue-soluble material and process for its manufacture |
US5716413A (en) * | 1995-10-11 | 1998-02-10 | Osteobiologics, Inc. | Moldable, hand-shapable biodegradable implant material |
AU2759397A (en) * | 1996-05-28 | 1998-01-05 | 1218122 Ontario Inc. | Resorbable implant biomaterial made of condensed calcium phosphate particles |
US5756651A (en) * | 1996-07-17 | 1998-05-26 | Chronopol, Inc. | Impact modified polylactide |
BR9711214A (en) * | 1996-08-23 | 2000-01-11 | Osteobiologics Inc | Device and process for measuring a compression property of a material, and processes for determining cartilage health or disease and for making the device. |
US5893850A (en) * | 1996-11-12 | 1999-04-13 | Cachia; Victor V. | Bone fixation device |
EP1018982B1 (en) * | 1996-12-03 | 2005-03-09 | Osteobiologics, Inc. | Biodegradable polymeric film |
US5733330A (en) * | 1997-01-13 | 1998-03-31 | Advanced Cardiovascular Systems, Inc. | Balloon-expandable, crush-resistant locking stent |
SE512050C2 (en) * | 1997-01-21 | 2000-01-17 | Nobel Biocare Ab | Rotationally symmetrical leg anchoring element |
US5977204A (en) * | 1997-04-11 | 1999-11-02 | Osteobiologics, Inc. | Biodegradable implant material comprising bioactive ceramic |
EP1014897B1 (en) * | 1997-05-30 | 2008-10-29 | Osteobiologics, Inc. | Fiber-reinforced, porous, biodegradable implant device |
GB9717433D0 (en) * | 1997-08-19 | 1997-10-22 | Univ Nottingham | Biodegradable composites |
US20020022588A1 (en) * | 1998-06-23 | 2002-02-21 | James Wilkie | Methods and compositions for sealing tissue leaks |
US6248430B1 (en) * | 1998-08-11 | 2001-06-19 | Dainippon Ink And Chemicals, Inc. | Lactic acid-based polymer laminated product and molded product |
SE515572C2 (en) * | 1998-09-09 | 2001-09-03 | Lanka Ltd | Implants, ways of making it and using it |
US6248108B1 (en) * | 1998-09-30 | 2001-06-19 | Bionx Implants Oy | Bioabsorbable surgical screw and washer system |
US6255408B1 (en) * | 1998-11-06 | 2001-07-03 | Poly-Med, Inc. | Copolyesters with minimized hydrolytic instability and crystalline absorbable copolymers thereof |
EP1148830A1 (en) * | 1999-02-04 | 2001-10-31 | Synthes Ag Chur | Bone screw |
US6296645B1 (en) * | 1999-04-09 | 2001-10-02 | Depuy Orthopaedics, Inc. | Intramedullary nail with non-metal spacers |
US7033603B2 (en) * | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
US6425923B1 (en) * | 2000-03-07 | 2002-07-30 | Zimmer, Inc. | Contourable polymer filled implant |
WO2002009768A2 (en) * | 2000-07-27 | 2002-02-07 | Rutgers, The State University | Therapeutic polyesters and polyamides |
AU8298201A (en) * | 2000-08-17 | 2002-02-25 | Tyco Healthcare | Sutures and coatings made from therapeutic absorbable glass |
ES2294026T3 (en) * | 2000-09-06 | 2008-04-01 | Ap Pharma, Inc. | DEGRADABLE POLYACETAL POLYMERS. |
US6605090B1 (en) * | 2000-10-25 | 2003-08-12 | Sdgi Holdings, Inc. | Non-metallic implant devices and intra-operative methods for assembly and fixation |
US6719935B2 (en) * | 2001-01-05 | 2004-04-13 | Howmedica Osteonics Corp. | Process for forming bioabsorbable implants |
US6749639B2 (en) * | 2001-08-27 | 2004-06-15 | Mayo Foundation For Medical Education And Research | Coated prosthetic implant |
US6841111B2 (en) * | 2001-08-31 | 2005-01-11 | Basf Corporation | Method for making a polyurea-polyurethane composite structure substantially free of volatile organic compounds |
US6916321B2 (en) * | 2001-09-28 | 2005-07-12 | Ethicon, Inc. | Self-tapping resorbable two-piece bone screw |
US20030125745A1 (en) * | 2001-11-05 | 2003-07-03 | Bio One Tech Inc. | Bone-fixing device |
BR0214610A (en) * | 2001-11-30 | 2004-09-14 | Pfizer | Controlled release polymeric compositions of bone growth promoting compounds |
WO2003059203A1 (en) * | 2001-12-21 | 2003-07-24 | Smith & Nephew, Inc. | Hinged joint system |
WO2003080119A1 (en) * | 2002-03-26 | 2003-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Responsive biomedical composites |
US20040024471A1 (en) * | 2002-06-27 | 2004-02-05 | Ferree Bret A. | Bone cell covered arthroplasty devices |
WO2004022000A2 (en) * | 2002-09-05 | 2004-03-18 | Ambrose Catherine G | Antibiotic microspheres for treatment of infections and osteomyelitis |
US7291345B2 (en) * | 2002-12-12 | 2007-11-06 | Osteotech, Inc. | Formable and settable polymer bone composite and method of production thereof |
EP1433489A1 (en) * | 2002-12-23 | 2004-06-30 | Degradable Solutions AG | Biodegradable porous bone implant with a barrier membrane sealed thereto |
EP1592728A2 (en) * | 2003-01-16 | 2005-11-09 | Carnegie-Mellon University | Biodegradable polyurethanes and use thereof |
US20070043376A1 (en) * | 2003-02-21 | 2007-02-22 | Osteobiologics, Inc. | Bone and cartilage implant delivery device |
WO2004082524A2 (en) * | 2003-03-13 | 2004-09-30 | William Marsh Rice University | Composite injectable and pre-fabricated bone replacement material and method for the production of such bone replacement material |
US7012106B2 (en) * | 2003-03-28 | 2006-03-14 | Ethicon, Inc. | Reinforced implantable medical devices |
EP1631206B1 (en) * | 2003-06-12 | 2007-10-10 | Synthes GmbH | Surgical nail |
FI120333B (en) * | 2003-08-20 | 2009-09-30 | Bioretec Oy | A porous medical device and a method of making it |
US7648504B2 (en) * | 2003-09-09 | 2010-01-19 | Bioretec Ltd | Bioabsorbable band system |
JP4251061B2 (en) * | 2003-10-03 | 2009-04-08 | ブリヂストンスポーツ株式会社 | Golf club head |
US7699879B2 (en) * | 2003-10-21 | 2010-04-20 | Warsaw Orthopedic, Inc. | Apparatus and method for providing dynamizable translations to orthopedic implants |
WO2005069884A2 (en) * | 2004-01-16 | 2005-08-04 | Osteobiologics, Inc. | Bone-tendon-bone implant |
US7378144B2 (en) * | 2004-02-17 | 2008-05-27 | Kensey Nash Corporation | Oriented polymer implantable device and process for making same |
EP1604693A1 (en) * | 2004-06-09 | 2005-12-14 | Scil Technology GmbH | In situ forming scaffold, its manufacturing and use |
US20060067971A1 (en) * | 2004-09-27 | 2006-03-30 | Story Brooks J | Bone void filler |
EP1883398A4 (en) * | 2005-02-01 | 2012-06-06 | Osteobiologics Inc | Method and device for selective addition of a bioactive agent to a multi-phase implant |
WO2007067625A2 (en) * | 2005-12-06 | 2007-06-14 | Tyco Healthcare Group Lp | Bioabsorbable surgical composition |
WO2007066339A1 (en) * | 2005-12-07 | 2007-06-14 | Ramot At Tel Aviv University Ltd. | Drug-delivering composite structures |
BRPI0620047A2 (en) * | 2005-12-21 | 2011-11-01 | Synthes Gmbh | bone plate set |
KR101102475B1 (en) * | 2006-06-28 | 2012-01-05 | 군제 가부시키가이샤 | Bio-degradable/absorbable polymer having reduced metal catalyst content, and process for production thereof |
US20080015578A1 (en) * | 2006-07-12 | 2008-01-17 | Dave Erickson | Orthopedic implants comprising bioabsorbable metal |
US8828419B2 (en) * | 2006-10-06 | 2014-09-09 | Cordis Corporation | Bioabsorbable device having encapsulated additives for accelerating degradation |
US8394488B2 (en) * | 2006-10-06 | 2013-03-12 | Cordis Corporation | Bioabsorbable device having composite structure for accelerating degradation |
US8480718B2 (en) * | 2006-12-21 | 2013-07-09 | Warsaw Orthopedic, Inc. | Curable orthopedic implant devices configured to be hardened after placement in vivo |
US7771476B2 (en) * | 2006-12-21 | 2010-08-10 | Warsaw Orthopedic Inc. | Curable orthopedic implant devices configured to harden after placement in vivo by application of a cure-initiating energy before insertion |
WO2009043099A1 (en) * | 2007-10-03 | 2009-04-09 | Polynovo Biomaterials Limited | High modulus polyurethane and polyurethane/urea compositions |
US8323322B2 (en) * | 2007-10-05 | 2012-12-04 | Zimmer Spine, Inc. | Medical implant formed from porous metal and method |
FI124190B (en) * | 2007-12-05 | 2014-04-30 | Bioretec Oy | Medical agent and preparation thereof |
-
2006
- 2006-08-16 CA CA002619571A patent/CA2619571A1/en not_active Abandoned
- 2006-08-16 US US12/064,156 patent/US20080305144A1/en not_active Abandoned
- 2006-08-16 WO PCT/GB2006/003049 patent/WO2007020432A2/en active Application Filing
- 2006-08-16 EP EP06765297A patent/EP1922091A2/en not_active Withdrawn
- 2006-08-16 JP JP2008526546A patent/JP2009504929A/en not_active Withdrawn
- 2006-08-16 AU AU2006281248A patent/AU2006281248A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0635274A2 (en) * | 1993-07-21 | 1995-01-25 | United States Surgical Corporation | Plasticizers for fibers used to form surgical devices |
WO2000001426A1 (en) * | 1998-07-07 | 2000-01-13 | Smith & Nephew Plc | Blend of bioresorbable polymers |
WO2001046501A2 (en) * | 1999-12-22 | 2001-06-28 | Kimberly-Clark Worldwide, Inc. | Synthetic fiber |
WO2003004071A1 (en) * | 2001-07-04 | 2003-01-16 | Smith & Nephew Plc | Biodegradable polymer systems |
WO2003064531A1 (en) * | 2002-01-31 | 2003-08-07 | Smith & Nephew Plc | High strength bioresorbables containing poly-glycolic acid |
WO2005014718A1 (en) * | 2003-07-19 | 2005-02-17 | Smith & Nephew Plc | High strength bioreabsorbable co-polymers |
Non-Patent Citations (1)
Title |
---|
GUPTA ET AL: "Poly(lactic acid) fiber: An overview" PROGRESS IN POLYMER SCIENCE, PERGAMON PRESS, OXFORD, GB, vol. 32, no. 4, 23 March 2007 (2007-03-23), pages 455-482, XP005935217 ISSN: 0079-6700 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007313009A (en) * | 2006-05-25 | 2007-12-06 | Terumo Corp | Stent |
US9815240B2 (en) | 2007-04-18 | 2017-11-14 | Smith & Nephew, Inc. | Expansion moulding of shape memory polymers |
US9770534B2 (en) | 2007-04-19 | 2017-09-26 | Smith & Nephew, Inc. | Graft fixation |
JP2015013182A (en) * | 2007-08-07 | 2015-01-22 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Coating |
AU2008285487B2 (en) * | 2007-08-07 | 2014-09-25 | Smith & Nephew Plc | Coating |
JP2010535563A (en) * | 2007-08-07 | 2010-11-25 | スミス アンド ネフュー ピーエルシー | Coating |
AU2014277686B2 (en) * | 2007-08-07 | 2016-05-05 | Smith & Nephew Plc | Coating |
JP2017042634A (en) * | 2007-08-07 | 2017-03-02 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Coating |
WO2009019477A3 (en) * | 2007-08-07 | 2010-01-21 | Smith & Nephew Plc | Coating |
WO2009019477A2 (en) * | 2007-08-07 | 2009-02-12 | Smith & Nephew Plc | Coating |
WO2010017153A3 (en) * | 2008-08-06 | 2011-03-31 | Medtronic, Inc. | Medical devices and methods including blends of biodegradable polymers |
CN102143766A (en) * | 2008-08-06 | 2011-08-03 | 麦德托尼克公司 | Medical devices and methods including blends of biodegradable polymers |
JP2011530331A (en) * | 2008-08-06 | 2011-12-22 | メドトロニック,インコーポレイテッド | Medical devices and methods comprising blends of biodegradable polymers |
US8129477B1 (en) | 2008-08-06 | 2012-03-06 | Medtronic, Inc. | Medical devices and methods including blends of biodegradable polymers |
Also Published As
Publication number | Publication date |
---|---|
US20080305144A1 (en) | 2008-12-11 |
WO2007020432A3 (en) | 2007-12-21 |
JP2009504929A (en) | 2009-02-05 |
EP1922091A2 (en) | 2008-05-21 |
CA2619571A1 (en) | 2007-02-22 |
AU2006281248A1 (en) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080305144A1 (en) | High Strength Devices and Composites | |
US20090274742A1 (en) | Multimodal high strength devices and composites | |
JP6995852B2 (en) | Absorbent polymer blend composition with improved nucleation rate | |
US9173978B2 (en) | Bioabsorbable polymeric compositions, processing methods, and medical devices therefrom | |
CA2452358C (en) | Biodegradable polymer systems | |
EP3293228B1 (en) | Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates | |
US9737629B2 (en) | Mechanically strong absorbable polymeric blend compositions of precisely controllable absorption rates, processing methods, and products therefrom | |
AU2014355033B2 (en) | Absorbable polymeric blend compositions with precisely controllable absorption rates, processing methods, and dimensionally stable medical devices therefrom | |
WO2016025329A1 (en) | Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof | |
Bai et al. | In vitro hydrolytic degradation of poly (para-dioxanone)/poly (D, L-lactide) blends | |
WO2009132021A1 (en) | Absorbable copolyesters of poly(ethoxyethylene diglycolate) and glycolide | |
CN1826380A (en) | High strength bioreabsorbable co-polymers | |
US20180325943A1 (en) | Biocompatible Articles With Embedded Copper Ions and Copper Ion Releasing Coating | |
WO2007110611A1 (en) | Composite material | |
JP2021529597A (en) | Easy-absorbing copolymer composition for high-strength sutures with improved post-embedding strength retention | |
EP3720514B1 (en) | Vacuum membrane thermoformed poly-4-hydroxybutyrate medical implants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006281248 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008526546 Country of ref document: JP Ref document number: 2006765297 Country of ref document: EP Ref document number: 2619571 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006281248 Country of ref document: AU Date of ref document: 20060816 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006281248 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006765297 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12064156 Country of ref document: US |